Toxoplasma gondii establishes latent infection in the central nervous system of immunocompentent hosts. Toxoplasmic encephalitis is a life threatening reactivation of latent infection in the brain of immunocompromised patients. To further understand the mechanisms of entry into the brain of T. gondii we investigated host molecules and cells involved in the passage of the parasite through the blood-brain barrier. First, using microarrays brain endothelial cells were found to upregulate, among others, chemokines and adhesion molecules following infection with tachyzoites. Using flow cytometry we observed upregulated ICAM-1 expression on the surface of brain endothelial cells following infection; ICAM-1 expression was further increased after pre-incubation with IFN-γ. Compared to RH tachyzoites, ME49 tachyzoites induced a stronger upregulation of ICAM-1 and an earlier and stronger IL-6 and MCP-1 secretion by brain endothelial cells. Using an in vitro coculture model of the BBB (primary glia cells and brain endothelial cells) we found a stronger migration of infected antigen-presenting cells compared to lymphocytes (4.63% vs. 0.6% of all cells) across the BBB. Among all antigen-presenting cells CD11b + /CD11c + cells showed the highest infection rate, whereas the majority of infected cells that migrated through the blood-brain barrier were CD11b + /CD11c − cells. Infection of PBMCs with type I or type II Toxoplasma strains resulted in similar patterns of cell migration across the in vitro BBB model. In conclusion, these results suggest that T. gondii modulates gene expression of brain endothelial cells to promote its own migration through the blood-brain barrier in a 'Trojan horse' manner. Cells expressing CD11b either with or without CD11c are likely candidate cells for the intracellular transport of T. gondii across the BBB. T. gondii type I and type II strains induced similar migration patterns of antigen-presenting cells across the in vitro BBB.
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Introduction
The blood-brain barrier is a selective cellular border at the level of specialized cerebral microvascular endothelial cells that protects the central nervous system (CNS) from blood-borne endangerments. The brain endothelial cells interacting with perivascular structures like pericytes, microglia and astroglia have characteristic properties defined by high transendothelial electrical resistance, the expression of tight junctions sealing the paracellular spaces, and a low pinocytotic activity (Abbott et al., 2006; Ge et al., 2005; Rubin and Staddon, 1999; Deli et al., 2005) . Although the CNS is routinely surveyed by cells of the immune system, inflammatory processes can lead to an excessive leukocyte infiltration into the brain and cause pathology (Hickey, 2001; Luster et al., 2005) as in patients with multiple sclerosis or AIDS dementia (McFarland and Martin, 2007; Nottet, 1999) . Under healthy conditions the endothelial cells of the blood-brain barrier express very low levels of adhesion molecules that could be used by leukocytes for transendothelial migration. Upon inflammatory stimulation, microvascular endothelial cells induce the expression of cell adhesion molecules including ICAM-1, VCAM-1, and selectins (Kadl and Leitinger, 2005; Coisne et al., 2006) . In concert with the secretion of various chemokines the vascular response implicates a decrease of blood-brain barrier function. Successful leukocyte trafficking thereby demands the interaction of selectins and their ligands as well as the cooperation of cell adhesion molecules with integrins or chemokines with their receptors (Ransohoff et al., 2003; Pober and Sessa, 2007) . Infections of the CNS are caused by a variety of extracellular (mostly causing meningitis) and intracellular pathogens (Kim, 2008; Marra and Brigham, 2001; Katti, 2004; Kim, 2002) . Whereas extracellular pathogens are believed to use the blood-cerebrospinal fluid barrier in the choroid plexus to gain access to the brain, intracellular pathogens including Listeria monocytogenes, Cryptococcus neoformans or the human immunodeficiency virus exploit host cells to transmigrate across host barriers (Drevets et al., 2004; Charlier et al., 2009; Kanmogne et al., 2007) . Infection with the protozoan parasite Toxoplasma gondii results in invasion of the brain Journal of Neuroimmunology 232 (2011) 119-130 
